COMPARISON OF A NEW FIRST-LINE TREATMENT IN HYPERTENSION VERSUS RAAS INHIBITOR-BASED FIRST-LINE STRATEGIES USING 24-HOUR AMBULATORY BLOOD PRESSURE MONITORING

被引：0
|
作者：
Parati, G. [1 ]
机构：
[1] Bicocca Univ, Milan, Italy
来源：
JOURNAL OF HYPERTENSION | 2016年 / 34卷
关键词：
D O I：
10.1097/01.hjh.0000492152.09088.24
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
PP.LB02.02
引用
收藏
页码：E280 / E280
页数：1
相关论文
共 50 条
  • [31] Hypertension and left ventricular mass in pediatrics: 24-hour ambulatory blood pressure monitoring versus office cuff pressure measurement
    Jiwani, AK
    Gauthier, B
    Trachtman, H
    Gandhi, MR
    Frank, R
    Bierman, FZ
    HYPERTENSION, 2002, 40 (03) : 424 - 424
  • [32] First-line treatment for Helicobacter pylori eradication: Levofloxacin/azithromycin-based strategies
    Nista, EC
    Candelli, M
    Fini, L
    Cazzato, IA
    Finizio, R
    Lauritano, C
    Di Gioacchino, G
    Tanturri, L
    Cammarota, G
    Gasbarrini, G
    Gasbarrini, A
    GASTROENTEROLOGY, 2004, 126 (04) : A191 - A191
  • [33] First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials
    Cabibbo, Giuseppe
    Reig, Maria
    Celsa, Ciro
    Torres, Ferran
    Battaglia, Salvatore
    Enea, Marco
    Rizzo, Giacomo Emanuele Maria
    Petta, Salvatore
    Calvaruso, Vincenza
    Di Marco, Vito
    Craxi, Antonio
    Singal, Amit G.
    Bruix, Jordi
    Camma, Calogero
    LIVER CANCER, 2021, : 75 - 84
  • [34] First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challenges
    Rizzo, Alessandro
    Ricci, Angela Dalia
    Gadaleta-Caldarola, Gennaro
    Brandi, Giovanni
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 15 (11) : 1245 - 1251
  • [35] IMPROVING HYPERTENSION CONTROL BY MOLECULAR STRATIFICATION OF FIRST-LINE NON-RESPONDERS USING RAAS TRIPLE-A TESTING
    Poglitsch, M.
    Ahmed, A. H.
    Guo, Z.
    Burrello, J.
    Stoller, A.
    Burkard, T.
    Domenig, O.
    Haschke, M.
    Mulatero, P.
    Stowasser, M.
    JOURNAL OF HYPERTENSION, 2019, 37 : E232 - E232
  • [36] FIRST-LINE IMMUNE CHECKPOINT INHIBITOR-BASED SEQUENTIAL THERAPIES FOR ADVANCED HEPATOCELLULAR CARCINOMA: A RATIONALE FOR FUTURE TRIALS
    Cabibbo, G.
    Celsa, C.
    Battaglia, S.
    Enea, M. .
    Rizzo, G. E. M.
    Busacca, A.
    Petta, S.
    Calvaruso, V.
    Di Marco, V.
    Craxi, A.
    Camma, C.
    DIGESTIVE AND LIVER DISEASE, 2021, 53 : S107 - S107
  • [37] Improving Hypertension Control By Molecular Stratification Of First-Line Non-Responders Using RAAS Triple-A Testing
    Poglitsch, Marko
    Burrello, Jacopo
    Ahmed, Ashraf H.
    Guo, Zeng
    Stoller, Andrea
    Burkard, Thilo
    Domenig, Oliver
    Haschke, Manuel
    Stowasser, Michael
    Mulatero, Paolo
    HYPERTENSION, 2019, 74
  • [38] Differences in GDM outcomes based on first-line treatment with oral agents versus insulin
    Edwards, Kayla
    Griffith, Taylor
    Masters, Heather R.
    DeFranco, Emily A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (01) : S343 - S343
  • [39] Prevalence of Masked Hypertension: a Population-Based Survey in a Large City by Using 24-Hour Ambulatory Blood Pressure Monitoring
    Rhee, Moo-Yong
    Kim, Sun-Woong
    Choi, Eun-Hee
    Kim, Ji-Hyun
    Nah, Deuk-Young
    Shin, Sung-Joon
    Gu, Namyi
    KOREAN CIRCULATION JOURNAL, 2016, 46 (05) : 681 - 687
  • [40] Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: comparison of a ritonavir-boosted protease inhibitor-based versus a nonnucleoside reverse transcriptase inhibitor-based first-line regimen
    Jarrin, I.
    Hernandez-Novoa, B.
    Alejos, B.
    Santos, I.
    Lopez-Aldeguer, J.
    Riera, M.
    Gutierrez, F.
    Rubio, R.
    Antela, A.
    Blanco, J. R.
    Moreno, S.
    HIV MEDICINE, 2014, 15 (09) : 547 - 556
12345